Ignite Creation Date:
2024-05-06 @ 8:29 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06397222
Status:
RECRUITING
Last Update Posted:
2024-05-07
First Post:
2024-04-29
Brief Title:
Sintilimab Plus Bevacizumab and SIRT for Intermediate-advanced HCC
Sponsor:
Organization:
Second Affiliated Hospital of Guangzhou Medical University